5 completed, 1 unknown. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 5, Unknown 1 |
Follow Secondary Hypogonadism: new trials by email Literature Review of Secondary Hypogonadism trials Research Report on Secondary Hypogonadism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men fispemifene, Placebo - Secondary Hypogonadism, Sexual Dysfunction | Phase 2 | Unknown | NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) | 160 | 2015-05-01 | 2015-11-13 |
| The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone) Androxal (enclomiphene citrate), Testosterone - Secondary Hypogonadism | Phase 2 | Completed | Repros Therapeutics Inc. | 60 | 2011-06-01 | 2015-09-23 |
| Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism Placebo, topical testosterone, Androxal - Secondary Hypogonadism | Phase 2 | Completed | Repros Therapeutics Inc. | 83 | 2011-01-01 | 2014-07-28 |
| Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus Placebo, Androxal - Type 2 Diabetes Mellitus, Secondary Hypogonadism | Phase 2 | Completed | Repros Therapeutics Inc. | 102 | 2010-10-01 | 2014-07-24 |
| Pharmacokinetic Study to Determine Time to Steady-state Testosterone undecanoate - Male Hypogonadism, Primary Hypogonadism | Phase 2 | Completed | Clarus Therapeutics, Inc. | 15 | 2009-07-01 | 2020-12-11 |
| To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone 25 mg Androxal, Testim 1% - Secondary Hypogonadism | Phase 2 | Completed | Repros Therapeutics Inc. | 17 | 2008-06-01 | 2015-08-19 |
Hypogonadism (6) · Diabetes Mellitus, Type 2 (1) · Erectile Dysfunction (1) · Eunuchism (1) · Sexual Dysfunction, Physiological (1)
Endocrine System Diseases (6) · Gonadal Disorders (6) · Diabetes Mellitus (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Glucose Metabolism Disorders (1) · Male Urogenital Diseases (1) · Mental Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Sexual Dysfunctions, Psychological (1) · Urogenital Diseases (1)
Enclomiphene (4) · Testosterone (3) · fispemifene (1) · testosterone undecanoate (1)
Repros Therapeutics Inc. (4) · Clarus Therapeutics, Inc. (1) · NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) (1)
United States (6)
Barbara Troupin, MD, MBA (1) · Glenn Cunningham, MD (1) · Gregory Flippo, MD (1) · Jolene Berg, MD (1) · Larry Lipshultz, MD (1) · Ronald Wiehle, PhD (1)